Abstract:OBJECTIVE:To observe the serial changes of plasma microparticle procoagulant activity in patients with traumatic brain injury (TBI) and evaluate its correlations with outcome and pathophysiology of TBI.METHODS:A total of 139 consecutive patients with isolated moderate or severe head trauma and 40 age- and sex-matched healthy controls were enrolled. Plasma samples were obtained on entry in healthy controls, as well as on admission and at day 1, day 2, day 3, day 5, and day 7 after TBI in the patients. Its concentration was measured by a prothrombinase assay.RESULTS:Fifty patients (36.0%) died from TBI in a month. After TBI, plasma microparticle procoagulant activity in the patients increased during the 6-hour period immediately, peaked in 24 hours and decreased gradually thereafter. It was substantially higher than that of healthy controls during the 7-day period using analysis of covariate (P < 0.01). A multivariate analysis selected plasma microparticle procoagulant activity (OR 1.432, 95% CI 1.194-1.719, P < 0. 01) as an independent predictor for 1-month mortality. Plasma microparticle procoagulant activities of non-survivals were statistically significantly higher than those of survivals (P = 0.01), and plasma microparticle procoagulant activities of patients with severe TBI were obviously higher than those of patients with moderate TBI (P = 0.002) using repeated-measures analysis. Plasma microparticle procoagulant activities of patients were negatively associated with Glasgow coma scale scores using Spearman correlation coefficient (P < 0.05). A multivariate linear regression selected plasma D-dimer level (P = 0.012) and plasma C-creative protein level (P = 0.019) related to plasma microparticle procoagulant activities. A receiver operating characteristic curve identified the cutoff levels of plasma microparticle procoagulant activities (12.2 U/ml) predicting 1-month mortality of patients with the high sensitivity (72.0%) and specificity values (85.4%). Areas under curve (AUC) of plasma resistin level (AUC = 0.847 +/- 0.037) was smaller than those of GCS scores (AUC = 0.917 +/- 0.023), but this difference failed to reach statistical significance (P = 0.104).CONCLUSION:Increased activity of plasma microparticle procoagulant is found after traumatic brain injury. It may contribute to inflammatory reaction and coagulation cascade and is associated with a poor clinical outcome.

Extracellular vesicles in disorders of hemostasis following traumatic brain injury

A Prosperous Application of Hydrogels with Extracellular Vesicles Release for Traumatic Brain Injury

Brain-derived Extracellular Vesicles Mediate Systemic Coagulopathy and Inflammation after Traumatic Brain Injury.

Change in Plasma Microparticle Procoagulant Activity after Traumatic Brain Injury

Clinical Theragnostic Signature of Extracellular Vesicles in Traumatic Brain Injury (TBI)

Circulating extracellular vesicles from patients with traumatic brain injury induce cerebrovascular endothelial dysfunction

Role of platelet-derived extracellular vesicles in traumatic brain injury-induced coagulopathy and inflammation

Anticoagulation Targeting Membrane-Bound Anionic Phospholipids Improves Outcomes of Traumatic Brain Injury in Mice.

Identification of novel blood-based extracellular vesicles biomarker candidates with potential specificity for traumatic brain injury in polytrauma patients

Changes in Coagulation following Brain Injury

Endothelial glycocalyx in traumatic brain injury associated coagulopathy: potential mechanisms and impact

The Role of Extracellular Vesicles in Traumatic Brain Injury-induced Acute Lung Injury.

Traumatic brain injury: Advances in coagulopathy (Review)

Extracellular Mitochondria in Traumatic Brain Injury Induced Coagulopathy.

Extracellular Vesicles: Therapeutic Potential in Central Nervous System Trauma by Regulating Cell Death.

Unraveling the Emerging Niche Role of Extracellular Vesicles (EVs) in Traumatic Brain Injury (TBI)

Pathogenesis and treatment progress of coagulation dysfunction after traumatic brain injury

The proteomic signature of circulating extracellular vesicles following intracerebral hemorrhage: Novel insights into mechanisms underlying recovery

Coagulopathy in Isolated Traumatic Brain Injury: Myth or Reality

Protein content of blood-derived extracellular vesicles: An approach to the pathophysiology of cerebral hemorrhage

Extracellular vesicle therapy for traumatic central nervous system disorders